EIF4EBP1 and breast carcinoma: Activity of eIF4E was estimated by combining these scores to reflect the inhibitory influence of 4E-BPs on eIF4E, and the activating influence of 4E-BP1 phosphorylation on eIF4E, using a formula previously derived from regression modelling of individual contributions of each component to prognosis in a large cohort of breast cancer patients: X-B1/4+PB1/2-B2/4, where X, B1, PB1 and B2 represent scores for eIF4E, 4E-BP1 phospho-4E-BP1 and 4E-BP2 respectively [31].